FrançaisAre analysts right about AdaptHealth Corp. (AHCO)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For AdaptHealth Corp., we replayed every analyst price target of the past 12 months and measured the real outcome: 27% were profitable, average return +9% (62 calls). At 3 months: +1% average return (37% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Truist Securities | 12 | 25% | -8% |
| SVB Leerink | 11 | 36% | +16% |
| RBC Capital | 10 | 30% | +5% |
| Baird | 9 | 0% | -18% |
| Canaccord Genuity | 7 | 0% | -15% |
Frequently asked questions
Is AdaptHealth Corp. a buy right now?
The analyst consensus on AdaptHealth Corp. (AHCO) is "Buy" (11 bullish, 0 bearish calls over 12 months). This is not advice: historically, 27% of their targets on this stock turned out profitable over 1 year.
What is AdaptHealth Corp.'s price target?
The median 12-month price target is $11.50 (+98% vs $5.80), ranging from $8.00 to $16.00 (6 analysts).
Are analysts accurate on AdaptHealth Corp.?
Over 1 year, 27% of analyst targets on AdaptHealth Corp. were profitable, for an average return of +9% (across 62 timestamped calls). This is JPI Invest's accuracy metric.
What is the AdaptHealth Corp. stock forecast?
Analysts target a median of $11.50 within 12 months, i.e. +98% vs the current price. The most bullish targets $16.00, the most cautious $8.00.
What is the AdaptHealth Corp. stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $11.50, +98%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (27%), and the stock's past trajectory.
Is AdaptHealth Corp. overvalued?
Detailed valuation data for AdaptHealth Corp. is available in the interactive analysis.
📊 See the full interactive analysis of AdaptHealth Corp. →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.